Lorlatinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Lorlatinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Lorlatinib included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 83% Pembrolizumab
- 63% Nintedanib
- 59% Trametinib
- 46% Cabozantinib
- 42% Vinorelbine
- 42% Osimertinib
- 42% Nivolumab
- 42% Ceritinib
- 42% Afatinib
- 41% Ibrutinib
- 38% Nitrosomethylurea
- 36% Abemaciclib
- 36% Sorafenib
- 34% Akalabrutinib
- 31% Palbociclib
- 31% Gefitinib
- 31% Ixazomib
- 30% Regorafenib
- 30% Ramucirumab
- 29% Topotecan
- 29% Vandetanib
- 29% Crizotinib
- 28% Ruxolitinib
- 28% Pazopanib
- 28% Pemetrexed
- 27% Ribociklib
- 26% Teniposide
- 24% Imatinib
- 24% Dabrafenib+Trametinib [set] [Dabrafenib and more 1Trametinib]
- 23% Irinotecan
- 23% Abiraterone
- 23% Dasatinib
- 23% Etoposide
- 23% Bosutinib
- 22% Vindesine
- 22% Carubicin
- 22% Vinflunine
- 22% Reslizumab
- 21% Atezolizumab
- 21% Cobimetinib
- 21% Vemurafenib
- 21% Dabrafenib
- 21% Benzotef
- 21% Idarubicin
- 21% Bleomycin
- 20% Tiotropium bromide
- 20% Docetaxel
- 19% Everolimus
- 18% Nilotinib
- 18% Hydrazine sulfate
Learn more about the selection of analogues
- The drug has «Lorlatinib» 51 analog by action, the most similar - Pembrolizumab .
- Medical online service has selected the best substitutes for Lorlatinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Lorlatinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.